SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRETTI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.340
EU - Europa 4.594
AS - Asia 2.743
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
AF - Africa 6
Totale 21.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.320
IT - Italia 1.695
CN - Cina 1.369
UA - Ucraina 886
DE - Germania 658
TR - Turchia 641
SG - Singapore 531
GB - Regno Unito 331
SE - Svezia 277
PL - Polonia 242
FI - Finlandia 199
ID - Indonesia 111
FR - Francia 101
RU - Federazione Russa 47
ES - Italia 27
BE - Belgio 23
IN - India 19
CZ - Repubblica Ceca 17
HK - Hong Kong 17
CH - Svizzera 13
NL - Olanda 13
VN - Vietnam 13
CA - Canada 12
IR - Iran 10
RO - Romania 10
BR - Brasile 9
EU - Europa 9
AT - Austria 8
JP - Giappone 8
MX - Messico 8
AU - Australia 7
EC - Ecuador 7
RS - Serbia 6
SM - San Marino 6
DK - Danimarca 5
IE - Irlanda 5
PT - Portogallo 5
CO - Colombia 4
EE - Estonia 4
KR - Corea 4
BD - Bangladesh 3
HU - Ungheria 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
TH - Thailandia 3
ZA - Sudafrica 3
AL - Albania 2
AR - Argentina 2
BG - Bulgaria 2
IL - Israele 2
MD - Moldavia 2
MY - Malesia 2
AM - Armenia 1
BY - Bielorussia 1
CY - Cipro 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 21.724
Salva come PNG Salva come JPEG
Città #
Fairfield 2.120
Woodbridge 1.929
Jacksonville 1.118
Houston 1.063
Chandler 951
Ashburn 937
Seattle 840
Wilmington 724
Cambridge 718
Ann Arbor 697
Izmir 462
Singapore 386
Nanjing 365
Princeton 284
Dearborn 237
Warsaw 237
Beijing 209
Ferrara 204
San Diego 170
Bremen 162
Milan 138
Boardman 130
Jakarta 111
Nanchang 105
Rome 92
Hebei 83
Falls Church 75
New York 73
Shenyang 70
Tianjin 67
Shanghai 65
Los Angeles 57
Changsha 52
Jiaxing 51
Bologna 50
Redwood City 48
Mountain View 47
Kunming 45
Santa Clara 44
Orange 40
London 38
Norwalk 37
Jinan 36
Naples 35
Hefei 28
Zhengzhou 25
Guangzhou 22
Ningbo 22
San Mateo 22
Brussels 21
Turin 21
Helsinki 19
Verona 18
Chicago 17
Hong Kong 17
Padova 15
Parma 15
Auburn Hills 14
Florence 14
Indiana 14
Lappeenranta 14
Redmond 14
Reggio Nell'emilia 14
Taizhou 13
Munich 12
Palermo 12
Des Moines 11
Lanzhou 11
St Petersburg 11
Torino 11
Brno 10
Catania 10
Changchun 10
Modena 10
Dallas 9
Dong Ket 9
Benevento 8
Foligno 8
Lucca 8
Paris 8
Tappahannock 8
Tokyo 8
Ardabil 7
Bolzano 7
Genova 7
Haikou 7
Imola 7
Kilburn 7
Pavia 7
Wuhan 7
Acquaviva 6
Amsterdam 6
Guayaquil 6
Napoli 6
Philadelphia 6
Pisa 6
Stockholm 6
Brescia 5
Cantalice 5
Centro 5
Totale 16.048
Salva come PNG Salva come JPEG
Nome #
Tumori Odontogeni misti: indagine sul significato delle correlazioni tra fibroma ameloblastico, fibro-odontoma ameloblastico e odontomi. 462
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 363
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 252
Survival of cancer patients in Europe: the EUROCARE study 231
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 221
I tumori in Emilia-Romagna 213
I tumori in Italia, rapporto 2007: sopravvivenza. 212
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 148
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 145
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 140
Completeness and timeliness: Cancer registries could/should improve their performance 130
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 129
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 129
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 128
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 128
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 125
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 123
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 122
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 122
International incidence of childhood cancer, 2001-10: a population-based registry study 120
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 119
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 118
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 115
Cancer prevalence estimates in Europe at the beginning of 2000 113
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 113
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 113
Impatto delle cure palliative sull'assistenza dei pazienti oncologici in fase terminale in provincia di Ferrara nel 2002. 111
Regional inequalities in cancer care persist in Italy and can influence survival. 111
Early (short-interval) rescreen in mammography screening 111
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 110
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 110
Estimates of cancer burden in Emilia-Romagna 109
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 108
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 108
Application of quantitative analysis to biologic profile evaluation in breast cancer 108
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 108
Epidemiology of rare cancers and inequalities in oncologic outcomes 108
Incidence, survival and prevalence of myeloid malignancies in Europe 107
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 107
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 107
Cancer incidence and mortality trends from 2003 to 2014 in Italy 107
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 106
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. 106
The burden of HPV-related diseases in Italy, 2001-12 106
Survival of European patients with central nervous system tumors 105
Breast screening: axillary lymph node status of interval cancers by interval year 104
null 104
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 104
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 103
Estimates of cancer burden in Italy 102
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 102
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 102
Comparative cancer survival information in Europe 102
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis 101
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 101
Changes in cervical cancer incidence following the introduction of organized screening in Italy 101
Treatment challenges in and outside a network setting: Soft tissue sarcomas 101
Estimated and observed cancer incidence in Italy: a validation study. 100
Rare cancers are not so rare: the rare cancer burden in Europe 100
Rare cancers of the head and neck area in Europe 100
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 99
Registro Tumori della provincia di Ferrara 98
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 98
Incidence and survival of rare urogenital cancers in Europe 98
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 98
null 98
Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study 98
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 98
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 98
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 98
Cancer incidence and mortality in the province of Ferrara 1989-1990 97
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening [Caratteristiche dei tumori del colon retto diagnosticati in Italia nei primi anni Duemila. Dati dello studio IMPATTO sdelo screening colorettale] 97
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 97
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 96
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 95
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 95
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 95
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 95
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 95
null 94
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study 94
null 94
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 94
null 93
null 93
null 93
Rare thoracic cancers, including peritoneum mesothelioma 93
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 93
National estimates of cancer patients survival in italy: A model-based method 92
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project 92
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary 92
null 92
Epidemiology of glial and non-glial brain tumours in Europe 92
Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project 91
Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study 91
Treatment challenges in and outside a network setting: Head and neck cancers 91
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 91
null 90
null 90
Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy 90
Totale 11.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.318
Totale 103.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.910 0 0 0 729 387 709 549 521 423 340 148 104
2020/20213.526 232 268 274 407 265 314 155 416 179 410 367 239
2021/20222.556 87 296 205 167 129 144 136 195 109 204 188 696
2022/20232.594 313 127 52 267 490 382 61 256 332 34 170 110
2023/20241.428 171 169 60 75 99 125 62 74 44 67 90 392
2024/2025889 209 148 529 3 0 0 0 0 0 0 0 0
Totale 22.222